Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: Toxicity and marker response - Editorial comment

Karlheinz Kurth

doi:10.1016/j.juro.2006.06.172

Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: Toxicity and marker response - Editorial comment

Karlheinz Kurth

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	1353
Journal	Journal of urology
Volume	176
Issue number	4 Part 1
DOIs	https://doi.org/10.1016/j.juro.2006.06.172
Publication status	Published - 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.juro.2006.06.172

Cite this

@article{cad76e66ca7b4d06ae7397277a21daa2,

title = "Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: Toxicity and marker response - Editorial comment",

author = "Karlheinz Kurth",

year = "2006",

doi = "10.1016/j.juro.2006.06.172",

language = "English",

volume = "176",

pages = "1353",

journal = "Journal of urology",

issn = "0022-5347",

publisher = "Elsevier Inc.",

number = "4 Part 1",

}

TY - JOUR

T1 - Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: Toxicity and marker response - Editorial comment

AU - Kurth, Karlheinz

PY - 2006

Y1 - 2006

U2 - 10.1016/j.juro.2006.06.172

DO - 10.1016/j.juro.2006.06.172

M3 - Editorial

SN - 0022-5347

VL - 176

SP - 1353

JO - Journal of urology

JF - Journal of urology

IS - 4 Part 1

ER -